Cohort 2 RAM Scholars: 2013-2015
Dr. Michael Dekker is an Addiction Psychiatry Fellow at Boston University, with high hopes to develop new methods of treatment for patients with addiction disorders. Growing up on the South Side of Chicago, exposure to patients with addictions started early. After living across the Nation and witnessing the ravages of Addiction, Michael chose to follow his father’s footsteps and enter into the field of treating Addiction disorders. Michael is new to clinical research, but is highly motivated. His research project is focused on Physician Directed Group Buprenorphine Administration. Ultimately, Michael hopes to work with American Indians and develop culturally appropriate treatment modalities for psychiatric and addiction disorders
Dr. Gomez completed her fellowship program in Child and Adolescent Psychiatry at St.’ Luke’s-Roosevelt Medical Center in New York City. With several years of experience in this field, she has contributed to the formation of innovative clinical programs for adults, children and adolescents affected by substance use disorders and comorbid conditions. Dr. Gomez is currently an Addiction Psychiatry fellow at Yale. She hopes to develop a better understanding of some of the factors associated with children, adolescents and young adults’ substance use and substance use disorders.
Dr Annie Levesque completed her medical school and a residency program in family medicine at University of Montreal. She is also a Master student at the department of experimental medicine of McGill University. She is an Addiction Medicine fellow at the Addiction Institute of New York (St. Luke’s and Roosevelt Hospital). Her current research interests are motivational interviewing and hepatitis C care among substance users.
Dr. Darcy Plott is currently a first year addiction medicine fellow at the Cincinnati VAMC / University of Cincinnati, having graduated from The Ohio State University College of Medicine. She is board-certified in internal medicine. Darcy also received an MPH from The Ohio State University and worked as a hospitalist prior to her current position. Her research project is exploring risk factors for opioid therapy dose escalation.